All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
REGN total return snapshot: REGN returned +17.95% over the past year and −20.48% YTD, with dividends reinvested. Since Apr. 2, 1991, REGN is up +2,821.64% in nominal total return, or +10.06%/yr, and is currently −48.64% below its total-return high on Aug. 27, 2024.
Data ending Fri Jun. 12, 2026
| Tue 1991-04-02💬 to Fri 2026-06-12 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| REGN × |
−20.48%
2026-06-12 |
+17.95%
2026-06-12 |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Tue 1991-04-02💬 to Fri 2026-06-12 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| REGN × |
+2,821.64%
+10.06%/yr |
+16.98%/yr
(R2=0.820) |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Tue 1991-04-02💬 to Fri 2026-06-12 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| REGN × |
$10,000.00
1991-04-02 |
$292,164.43
2026-06-12 |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Year | REGN |
|---|---|
| 2026 (YTD) | −20.48% |
| 2025 | +8.96% |
| 2024 | −18.90% |
| 2023 | +21.73% |
| 2022 | +14.25% |
| 2021 | +30.72% |
| 2020 | +28.66% |
| 2019 | +0.53% |
| 2018 | −0.65% |
| 2017 | +2.42% |
| 2016 | −32.38% |
| 2015 | +32.33% |
| 2014 | +49.05% |
| 2013 | +60.89% |
| 2012 | +208.62% |
| 2011 | +68.84% |
| 2010 | +35.77% |
| 2009 | +31.70% |
| 2008 | −23.98% |
| 2007 | +20.33% |
| 2006 | +26.23% |
| 2005 | +72.64% |
| 2004 | −37.39% |
| 2003 | −20.53% |
| 2002 | −34.27% |
| 2001 | −20.15% |
| 2000 | +176.59% |
| 1999 | +72.88% |
| 1998 | −13.87% |
| 1997 | −46.90% |
| 1996 | +26.47% |
| 1995 | +325.01% |
| 1994 | −80.65% |
| 1993 | +29.17% |
| 1992 | −33.79% |
| 1991 | −14.20% |
| Tue 1991-04-02💬 to Fri 2026-06-12 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| REGN × |
−48.64%
from 2024-08-27 peak |
−91.81%
2005-04-14 from 2000-02-29 peak |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Period ending Fri 2026-06-12 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| REGN × | +17.95% |
−39.94% −22.50%/yr |
−18.14% −6.46%/yr |
+17.44% +3.27%/yr |
+65.90% +5.19%/yr |
|
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||